Natural compound shows promise against C. difficile while largely sparing healthy gut bacteria https://medicalxpress.com/news/2026-10-natural-compound-difficile-largely-healthy.html Argyrin B exhibits potent therapeutic efficacy in a Clostridioides difficile-infection mouse model while preserving microbiota functionality https://www.nature.com/articles/s44259-026-00248-x "Clostridioides difficile infection (CDI) remains a leading cause of antibiotic-associated diarrhoea, with high recurrence rates and limited treatment options that preserve gut microbiota. Current treatments, including vancomycin, further disrupt the already compromised gut microbiota, often prolonging dysbiosis and increasing the risk of colonization by resistant pathogens"